Back
Axsome Therapeutics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40
AXSM
Axsome Therapeutics
Last Price:
$109.69
Seasonality Move:
-7.42%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and AXSM is experiencing selling pressure, which indicates risk of future bearish movement.
Axsome Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 111.22 | Buy |
20-day SMA: | 106.93 | Buy |
50-day SMA: | 106.84 | Buy |
200-day SMA: | 103.6 | Buy |
8-day EMA: | 110.61 | Buy |
20-day EMA: | 108.53 | Buy |
50-day EMA: | 107.74 | Buy |
200-day EMA: | 103.1 | Buy |
Axsome Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.64 | Buy |
Relative Strength Index (14 RSI): | 58.82 | Buy |
Chaikin Money Flow: | -268888 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (102.33 - 110.09) | Buy |
Bollinger Bands (100): | (102.09 - 119.75) | Buy |
Axsome Therapeutics Technical Analysis
Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Axsome Therapeutics Stock
Is Axsome Therapeutics Stock a Buy?
-
Axsome Therapeutics share price is 111.70 while AXSM 8-day simple moving average is 111.22, which is a Buy signal.
-
The stock price of AXSM is 111.70 while Axsome Therapeutics 20-day SMA is 106.93, which makes it a Buy.
-
Axsome Therapeutics 50-day simple moving average is 106.84 while AXSM share price is 111.70, making it a Buy technically.
-
AXSM stock price is 111.70 and Axsome Therapeutics 200-day simple moving average is 103.60, creating a Buy signal.
AXSM Technical Analysis vs Fundamental Analysis
Sell
40
Axsome Therapeutics (AXSM)
is a Sell
Is Axsome Therapeutics a Buy or a Sell?
-
Axsome Therapeutics stock is rated a SellThe current Axsome Therapeutics [AXSM] share price is $111.70. The Score for AXSM is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
Axsome Therapeutics Stock Info
Market Cap:
5.5B
Price in USD:
111.70
Share Volume:
453.7K
Axsome Therapeutics 52-Week Range
52-Week High:
139.13
52-Week Low:
72.21
Sell
40
Axsome Therapeutics (AXSM)
is a Sell
Axsome Therapeutics Share Price Forecast
-
What is the Axsome Therapeutics stock price today?The Axsome Therapeutics stock price is 111.70 USD today.
-
Will AXSM stock go up or go down?Axsome Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Axsome Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Axsome Therapeutics is overvalued.
Is Axsome Therapeutics Stock a Buy?
-
Axsome Therapeutics share price is 111.70 while AXSM 8-day exponential moving average is 110.61, which is a Buy signal.
-
The stock price of AXSM is 111.70 while Axsome Therapeutics 20-day EMA is 108.53, which makes it a Buy.
-
Axsome Therapeutics 50-day exponential moving average is 107.74 while AXSM share price is 111.70, making it a Buy technically.
-
AXSM stock price is 111.70 and Axsome Therapeutics 200-day simple moving average is 103.10, creating a Buy signal.
Fundamental Analysis of Axsome Therapeutics
Is Axsome Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.56 per share, an increase next quarter of $0.93 per share, an increase this year of $1.62 per share, and an increase next year of $5.02 per share.
Technical Analysis of Axsome Therapeutics
Should I short Axsome Therapeutics stock?
-
AXSM Moving Average Covergence Divergence (MACD) indicator is 1.64, suggesting Axsome Therapeutics is a Buy
-
Axsome Therapeutics Relative Strength Index (RSI) is 58.82, which suggest Axsome Therapeutics is overbought
-
The Bollinger Bands (25) for Axsome Therapeutics is (102.33 - 110.09), which suggest Axsome Therapeutics is a Buy
-
The Bollinger Bands (100) for Axsome Therapeutics is (102.09 - 119.75), which suggest Axsome Therapeutics is a Buy
* Axsome Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.